Cannabidiol for epilepsy, absence

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 8 Nov 2017: Trial registered, NCT03336242
  2. 28 Nov 2017: Trial registered, NCT03355300
  3. 29 Dec 2017: Trial started, NCT03336242
  4. 20 Feb 2018: Trial started, NCT03355300
  5. 29 May 2019: Trial terminated, NCT03336242
  6. 28 Jun 2019: Trial terminated, NCT03355300
  7. 18 Jun 2023: Trial results posted, NCT03355300
  8. 21 Jul 2023: Trial results posted, NCT03336242

The trials

NCT03336242: Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

State
Stopped early
Phase
Phase 2
People
20 taking part
Started
29 Dec 2017
Primary completion
15 May 2019
Arms
Cohort 1: Cannabidiol Oral Solution 20 mg/kg/day, Cohort 2: Cannabidiol Oral Solution 30 mg/kg/day, Cohort 3: Cannabidiol Oral Solution 10 mg/kg/day
Results
Posted on the registry
  1. 8 Nov 2017: Trial registered
  2. 29 Dec 2017: Trial started
  3. 29 May 2019: Trial terminated
  4. 21 Jul 2023: Trial results posted

NCT03355300: Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

State
Stopped early
Phase
Phase 2
People
11 taking part
Started
20 Feb 2018
Primary completion
24 Jun 2019
Arms
Cannabidiol Oral Solution
Results
Posted on the registry
  1. 28 Nov 2017: Trial registered
  2. 20 Feb 2018: Trial started
  3. 28 Jun 2019: Trial terminated
  4. 18 Jun 2023: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Also known as Cardiolrx, Canapure PH, Cannabidiol (Epidiolex), Cannabidiol Oral Solution, Epidiolex, Epidiolex 100 mg/mL Oral Solution, Epidyolex, GWP42003-P 10 mg/kg/day Dose, GWP42003-P 20 mg/kg/day Dose, GWP42003-P 5 mg/kg/day Dose, MediCabilis.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.